Locations
England, UK · London, UK · Oxford, UK · Mile End, London, UK · Kingston Vale, London SW15, UK
industry
Biotechnology
Size
11-50 employees
Stage
Series A
founded in
2021
Amber Therapeutics is a University of Oxford spinout developing next-generation, intelligent bioelectrical therapies to transform clinical outcomes in patients with functional disorders of the peripheral nervous system. Amber’s approach leverages closed-loop intelligence to create ‘synthetic reflex arcs’ that can sense, interpret, adapt, and respond to a patient’s individual signals, thereby restoring normal physiological function. Amber Therapeutics was founded by a multidisciplinary team of clinicians, translational neuroengineers, MedTech industry professionals, and experienced entrepreneurs focused on developing transformational therapy innovation for major unmet medical conditions. The company was spun out from the University of Oxford in 2021 and is backed by Oxford Science Enterprises and 8VC.
Something looks off?On-site & Remote